Infinium Pharmachem Limited (NSE: INFINIUM), ISIN INE0MRE01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INFINIUM last traded at ₹206.00 (-0.02%), with a 52-week range of ₹189.40 to ₹283.50 (as of 29 Jul 2026).
Shareholding as of Mar 2026: promoters 64.91%, FIIs 0.00%, DIIs 0.21%, mutual funds 0.00%.
EquiSense Score (ECS): 82/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.